EMEA-000662-PIP02-09-M03

Key facts

Active substance
  • aluminium hydroxide adsorbed
  • depigmented glutaraldehyde polymerised
  • alder pollen
  • birch pollen
  • hazel pollen
Therapeutic area
Pneumology-allergology
Decision number
P/0014/2014
PIP number
EMEA-000662-PIP02-09-M03
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Treatment of allergic rhinitis / rhino-conjunctivitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Leti Pharma GmbH
Germany
E-mail: paediatrics@leti.de
Tel. +49 230 2202 860
Fax +49 230 2202 8623
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating